A
Alnylam Pharmaceuticals
26 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.
Org chart
Collapse
Pushkal Garg
Chief Medical Officer
Jeff Poulton
CFO
Vasant Jadhav
Chief Technology Officer
Kevin Fitzgerald
Chief Scientific Officer
Timothy Maines
Chief Technical Operations & Quality Officer
Christine Lindenboom
Chief Corporate Communications Officer
Kasha Witkos
SVP, International Region Head
Julie Milner
VP Head Of International Regulatory Affairs
Priya Sankar
Vice President, General Counsel, Global Research & Development
Robert Hesslein
Chief Legal Officer & Corporate Secretary
Mike Tirozzi
Svp, Chief Information And Data Officer
Melissa Mclaughlin
Chief Human Resources Officer
Daniel Lee
VP Enterprise Strategy And Portfolio Analytics
Lawrence Egan
VP Strategic Technologies
Stephen Listzwan
Vice President, Global Strategic Sourcing
Sally Collins
Vice President, Head Of International, Rare Disease
Simon Fox
Vice President, Program Lead, Developmemt Programs
Board & advisors
Amy W. Schulman
Chair
Colleen Reitan
Director
David E.i. Pyott
Board Member
Dennis A. Ausiello
Director
Margaret A. Hamburg
Director
Michael W. Bonney
Director
Olivier Brandicourt
Director
Phillip A. Sharp
Director
Elliott Sigal
Director
Peter N. Kellogg
Director
Carolyn Bertozzi
Director